References
- Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, Sidhu SB. Pheochromocytoma: current approaches and future directions. Oncologist 13, 779–793, 2008.10.1634/theoncologist.2008-004318617683
- Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv 54, 728–737, 1999.10.1097/00006254-199911000-0002510546277
- Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP, Plouin PF. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92, 3822–3828, 2007.10.1210/jc.2007-07091765221217652212
- Amar L, Fassnacht M, Gimenez-Roqueplo A, Januszewicz A, Prejbisz A, Timmers H, Plouin PF. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma. Horm Metab Res 44, 385–389, 2012.2235147810.1055/s-0031-130133922351478
- Andrade MO, Cunha VSD, Oliveira DC, Moraes OL, Lofrano-Porto A. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature. Arch Endocrinol Metab 62, 264–269, 2018.10.20945/2359-399700000003329768630
- Arnaldi G, Boscaro M. Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 26, 405–419, 2012.10.1016/j.beem.2011.12.00622863384
- Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 150, 681–686, 2004.10.1530/eje.0.150068115132724
- Baudin E. Treatment of malignant pheochromocytomas and paragangliomas. Endocrine Abstracts 32, S14.3, 2013.10.1530/endoabs.32.S14.3
- Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, Walz MK, Peczkowska M, Weryha G, Dall’igna P, Cecchetto G, Bisogno G, Moeller LC, Bockenhauer D, Patocs A, Racz K, Zabolotnyi D, Yaremchuk S, Dzivite-Krisane I, Castinetti F, Taieb D, Malinoc A, von Dobschuetz E, Roessler J, Schmid KW, Opocher G, Eng C, Neumann HP. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21, 17–25, 2013.10.1530/ERC-13-041524169644
- Bausch B, Tischler AS, Schmid KW, Leijon H, Eng C, Neumann HPH. Max Schottelius: pioneer in pheochromocytoma. J Endocr Soc 1, 957–964, 2017.10.1210/js.2017-00208568915029264546
- Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA, Suarez C, Hussain AK, Vriends AH, Hes FJ, Jansen JC, Tops CM, Corssmit EP, de Knijff P, Lenders JW, Cremers CW, Devilee P, Dinjens WN, de Krijger RR, Robledo M. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11, 366–372, 2010.10.1016/S1470-2045(10)70007-3
- Bednarczuk T, Bolanowski M, Sworczak K, Gornicka B, Cieszanowski A, Otto M, Ambroziak U, Pachucki J, Kubicka E, Babinska A, Koperski L, Januszewicz A, Prejbisz A, Gorska M, Jarząb B, Hubalewska-Dydejczyk A, Glinicki P, Ruchała M, Kasperlik-Zaluska A. Adrenal incidentaloma in adults - management recommendations by the Polish Society of Endocrinology. Endokrynol Pol 67, 234–258, 2016.10.5603/EP.a2016.003927082051
- Bessell-Browne R, O’Malley ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol 188, 970–974, 2007.10.2214/AJR.06.082717377032
- Bholah R, Bunchman TE. Review of pediatric pheochromocytoma and paraganglioma. Front Pediatr 5, 155, 2017.10.3389/fped.2017.00155550801528752085
- Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg 100, 182–190, 2013.10.1002/bjs.897623180595
- Bjorklund P, Pacak K, Crona J. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts. J Intern Med 280, 559–573, 2016.10.1111/joim.12507744182527165774
- Blake MA, Krishnamoorthy SK, Boland GW, Sweeney AT, Pitman MB, Harisinghani M, Mueller PR, Hahn PF. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 181, 1663–1668, 2003.10.2214/ajr.181.6.181166314627592
- PDQ Adult Treatment Editorial Board. Pheochromocytoma and Paraganglioma Treatment (PDQ®): Health Professional Version. 2018 Feb 8. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65873/.
- Bowerman RA, Silver TM, Jaffe MH, Stuck KJ, Hinerman DL. Sonography of adrenal pheochromocytomas. AJR Am J Roentgenol 137, 1227–1231, 1981.10.2214/ajr.137.6.12276976097
- Bozin M, Lamb A, Putra LJ. Pheochromocytoma with negative metanephrines: A rarity and the significance of dopamine secreting tumors. Urol Case Rep 12, 51–53, 2017.10.1016/j.eucr.2017.02.002536213628337414
- Briere JJ, Favier J, Benit P, El Ghouzzi V, Lorenzato A, Rabier D, Di Renzo MF, Gimenez-Roqueplo AP, Rustin P. Mitochondrial succinate is instrumental for HIF1a nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Hum Mol Genet 14, 3263–3269, 2005.10.1093/hmg/ddi35916195397
- Brito JP, Asi N, Gionfriddo MR, Norman C, Leppin AL, Zeballos-Palacios C, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH. The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review. Endocrine 50, 176–186, 2015.10.1007/s12020-015-0544-725663601
- Brunaud L, Boutami M, Nguyen-Thi PL, Finnerty B, Germain A, Weryha G, Fahey TJ 3rd, Mirallie E, Bresler L, Zarnegar R. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 156, 1410–1418, 2014.10.1016/j.surg.2014.08.02225456922
- Brunt LM, Doherty GM, Norton JA, Soper NJ, Quasebarth MA, Moley JF. Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 183, 1–10, 1996.
- Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, de Herder WW, Kazemier G. Risk Ffactors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab 95, 678–685, 2010.10.1210/jc.2009-105119965926
- Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95, 1196–1204, 2003.10.1093/jnci/djg02412928344
- Burgess GE 3rd. Alpha blockade and surgical intervention of pheochromocytoma in pregnancy. Obstet Gynecol 53, 266–270, 1979.
- Burnichon N, Abermil N, Buffet A, Favier J, Gimenez-Roqueplo AP. The genetics of paragangliomas. Eur Ann Otorhinolaryngol Head Neck Dis 129, 315–318, 2012.10.1016/j.anorl.2012.04.00723078982
- Burnichon N, Buffet A, Gimenez-Roqueplo AP. Pheochromocytoma and paraganglioma: molecular testing and personalized medicine. Curr Opin Oncol 28, 5–10, 2016.10.1097/CCO.000000000000024926599293
- Castinetti F. Outcome of adrenal sparing surgery in heritable pheochromocytoma: the example of multiple endocrine neoplasia type 2. Endocrine Abstracts 37, S12.3, 2015.10.1530/endoabs.37.S12.3
- Castro-Vega LJ, Buffet A, De Cubas AA, Cascon A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre O, Curras-Freixes M, Franco-Vidal V, Guillaud-Bataille M, Simian C, Morin A, Leton R, Gomez-Grana A, Pollard PJ, Rustin P, Robledo M, Favier J, Gimenez-Roqueplo AP. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23, 2440–2446, 2014.10.1093/hmg/ddt63924334767
- Chang A, Glazer HS, Lee JK, Ling D, Heiken JP. Adrenal gland: MR imaging. Radiology 163, 123–128, 1987.10.1148/radiology.163.1.38234233823423
- Cheah WK, Clark OH, Horn JK, Siperstein AE, Duh Q. Laparoscopic adrenalectomy for pheochromocytoma. World J Surg 26, 1048–1051, 2002.10.1007/s00268-002-6669-x12045856
- Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K; North American Neuroendocrine Tumor Society (NANETS). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39, 775–783, 2010.10.1097/MPA.0b013e3181ebb4f0341900720664475
- Chen Y, Hodin RA, Pandolfi C, Ruan DT, McKenzie TJ. Hypoglycemia after resection of pheochromocytoma. Surgery 156, 1404–1409, 2014.10.1016/j.surg.2014.08.02025456920
- Cho YY, Suh S, Joung JY, Jeong H, Je D, Yoo H, Park TK, Min YK, Kim KW, Kim JH. Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. Korean J Intern Med 28, 557–564, 2013.10.3904/kjim.2013.28.5.55724009451375976124009451
- Choi EK, Kim WH, Park KY. A case of a composite adrenal medullary tumor of pheochromocytoma and ganglioneuroma masquerading as acute pancreatitis. Korean J Intern Med 21, 141–145, 2006.1691344710.3904/kjim.2006.21.2.141389073916913447
- Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer 14, 569–585, 2007.10.1677/ERC-07-007417914089
- Comstock JM, Willmore-Payne C, Holden JA, Coffin CM. Composite pheochromocytoma: a clinicopathologic and molecular comparison with ordinary pheochromocytoma and neuroblastoma. Am J Clin Pathol 132, 69–73, 2009.10.1309/AJCPN76VTIGWPOAG19864235
- Crona J, Delgado Verdugo A, Maharjan R, Stålberg P, Granberg D, Hellman P, Bjorklund P. Somatic mutations in HRAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. J Clin Endocrinol Metab 98, E1266–E1271, 2013.10.1210/jc.2012-425723640968
- Crona J, Taieb D, Pacak K. New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr Rev 38, 489–515, 2017.10.1210/er.2017-00062571682928938417
- Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14, 108–119, 2014.10.1038/nrc364824442145
- Dahia PL. Pheochromocytomas and paragangliomas, genetically diverse and minimalist, all at once! Cancer Cell 31, 159–161, 2017.10.1016/j.ccell.2017.01.0092819658728196587
- Dean RE. Pheochromocytoma and pregnancy. Obstet Gynecol 11, 35–42, 1958.
- Delellis RA, Lloyd RV, Heitx PU. Pathology and genetics of tumors of endocrine organs. In World Health Organization of Tumours. IARC, Lyon, pp. 73–76, 2004.
- Desmonts JM, Marty J. Anaesthetic management of patients with phaeochromocytoma. Br J Anaesth 56, 781–789, 1984.637570810.1093/bja/56.7.7816375708
- Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol 179, 559–568, 2002.10.2214/ajr.179.3.179055912185019
- Dunwoodie SL. The role of hypoxia in development of the Mammalian embryo. Dev Cell 17, 755–773, 2009.2005994710.1016/j.devcel.2009.11.00820059947
- Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true-from false-positive test results. J Clin Endocrinol Metab 88, 2656–2666, 2003.10.1210/jc.2002-0300051278887012788870
- Eisenhofer G, Lenders JW, Pacak K. Biochemical diagnosis of pheochromocytoma. Front Horm Res 31, 76–106, 2004a.10.1159/00007465914674306
- Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein DS, Lehnert H, Manger WM, Maris JM, Neumann HP, Pacak K, Shulkin BL, Smith DI, Tischler AS, Young WF Jr. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11, 423–436, 2004b.10.1677/erc.1.0082915369446
- Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90, 2068–2075, 2005.1564439710.1210/jc.2004-202515644397
- Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 57, 411–420, 2011.2126295110.1373/clinchem.2010.153320316499821262951
- Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer 48, 1739–1749, 2012.10.1016/j.ejca.2011.07.016337262422036874
- Eisenhofer G, Prejbisz A, Peitzsch M, Pamporaki C, Masjkur J, Rogowski-Lehmann N, Langton K, Tsourdi E, Pęczkowska M, Fliedner S, Deutschbein T, Megerle F, Timmers HJLM, Sinnott R, Beuschlein F, Fassnacht M, Januszewicz A, Lenders JWM. Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites. Clin Chem 64, 1646–1656, 2018.10.1373/clinchem.2018.2913693009749830097498
- Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89, 193–201, 2005.10.1002/jso.2017715719371
- Elsayes KM, Mukundan G, Narra VR, Lewis JS Jr, Shirkhoda A, Farooki A, Brown JJ. Adrenal masses: MR imaging features with pathologic correlation. Radiographics 24, S73–S86, 2004.10.1148/rg.24si04551415486251
- Evenepoel L, Papathomas TG, Krol N, Korpershoek E, de Krijger RR, Persu A, Dinjens WN. Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations. Genet Med 17, 610–620, 2015.10.1038/gim.2014.1622539417625394176
- Farrugia FA, Georgios M, Panagiotis T, Nikolaos Z, Anestis C, Dimitrios S, Nikolaoes K, Anna P, Erini K, Machairas A. Adrenal incidentaloma or epinephroma and review of the literature. Differential diagnosis of adrenal incidentaloma. Khirurgiia 82, 120–128, 2016.
- Farrugia FA. “Ephidrosis,” Is a New Term to Replace the Term “Diaphoresis” J Ren Nutr 27, 445, 2017.10.1053/j.jrn.2017.08.00929056161
- Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, Sotiropoulos D. Pheochromocytoma, diagnosis and treatment: Review of the literature. Endocr Regul 51, 168–181, 2017.10.1515/enr-2017-001828858847
- Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11, 101–111, 2015.10.1038/nrendo.2014.18825385035
- Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network, Pacak K, Nathanson KL, Wilkerson MD. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181–193, 2017.10.1016/j.ccell.2017.01.001564315928162975
- Flynn A, Benn D, Clifton-Bligh R, Robinson B, Trainer AH, James P, Hogg A, Waldeck K, George J, Li J, Fox SB, Gill AJ, McArthur G, Hicks RJ, Tothill RW. The genomic landscape of phaeochromocytoma. J Pathol 236, 78–89, 2015.10.1002/path.450325545346
- Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin North Am 34, 1101–1112, 1996.10.1016/S0033-8389(22)00693-5
- Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 327, 1033, 1992.10.1056/NEJM1992100132714171387700
- Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A. Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg 226, 238–247, 1997.10.1097/00000658-199709000-0000311910159339930
- Galati SJ, Said M, Gospin R, Babic N, Brown K, Geer EB, Kostakoglu L, Krakoff LR, Leibowitz AB, Mehta L, Muller S, Owen RP, Pertsemlidis DS, Wilck E, Xiao GQ, Levine AC, Inabnet WB 3rd. The Mount Sinai clinical pathway for the management of pheochromocytoma. Endocr Pract 21, 368–382, 2015.10.4158/EP14036.RA25297659
- Giannini AJB, Henry R, Goettsche, Roger L. Psychiatric, Psychogenic and Somatopsychic Disorders Handbook. M. Examination. Garden City, NY, 1978.
- Goffredo P, Sosa JA, Roman SA. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades. J Surg Oncol 107, 659–664, 2013.10.1002/jso.2329723233320
- Goldstein M, Fuxe K, Hokfelt T. Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol Rev 24, 293–309, 1972.4564603
- Goldstein RE, O’Neill JA Jr, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW 3rd, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN, Scott HW Jr. Clinical experience over 48 years with pheochromocytoma. Ann Surg 229, 755–766, 1999.10.1097/00000658-199906000-00001142082110363888
- Graham JB. Pheochromocytoma and hypertension; an analysis of 207 cases. Int Abstr Surg 92, 105–121, 1951.
- Gregory SH, Yalamuri SM, McCartney SL, Shah SA, Sosa JA, Roman S, Colin BJ, Lentschener C, Munroe R, Patel S, Feinman JW, Augoustides JG. Perioperative management of adrenalectomy and inferior vena cava reconstruction in a patient with a large, malignant pheochromocytoma with vena caval extension. J Cardiothorac Vasc Anesth 31, 365–377, 2017.10.1053/j.jvca.2016.07.01927810406
- Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 118, 182–189, 2017.2810052110.1093/bja/aew39228100521
- Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg 216, 280–289, 2013.10.1016/j.jamcollsurg.2012.10.01223317575
- Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH, Duh QY. Clinical spectrum of pheochromocytoma. J Am Coll Surg 209, 727–732, 2009.10.1016/j.jamcollsurg.2009.09.02219959041
- Gunawardane PTK, Grossman A. Phaeochromocytoma and paraganglioma. In: Hypertension: from basic research to clinical practice, Vol. 2, (Ed. Md. Shahidul Islam), Springer, pp. 239–259, 2017.10.1007/5584_2016_7627888488
- Gut P, Czarnywojtek A, Fischbach J, Baczyk M, Ziemnicka K, Wrotkowska E, Gryczynska M, Ruchala M. Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls. Arch Med Sci 12, 1–9, 2016.10.5114/aoms.2016.57577475436426925113
- Hack HA. The perioperative management of children with phaeochromocytoma. Paediatr Anaesth 10, 463–476, 2000.1101294910.1046/j.1460-9592.2000.00504.x11012949
- Halkertson IDK. A Wiley Medical Publication: Biochemistry, John Wiley & Sons, 1988.
- Harari A, Inabnet WB 3rd. Malignant pheochromocytoma: a review. Am J Surg 201, 700–708, 2011.10.1016/j.amjsurg.2010.04.01220870212
- Harrington JL, Farley DR, van Heerden JA, Ramin KD. Adrenal tumors and pregnancy. World J Surg 23, 182–186, 1999.10.1007/PL000131599880429
- Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 52, 419–429, 2008.
- Havekes B, King K, Lai EW, Romijn JA, Corssmit EP, Pacak K. New imaging approaches to phaeochromocytomas and paragangliomas. Clin Endocrinol (Oxf) 72, 137–145, 2010.10.1111/j.1365-2265.2009.03648.x296697319508681
- Hickman PE, Leong M, Chang J, Wilson SR, McWhinney B. Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma. Pathology 41, 173–177, 2009.10.1080/003130208025792841915219019152190
- Hofer M. Ultrasound Teaching Manual. The Basics of Performing and Interpreting Ultrasound Scans. Thieme Stuttgart, New York, 1999.
- Hrascan R, Pecina-Slaus N, Martic TN, Colic JF, Gall-Troselj K, Pavelic K, Karapandza N Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas. J Neuroendocrinol 20, 1015–1022, 2008.10.1111/j.1365-2826.2008.01755.x18510707
- Huang LE, Bindra RS, Glazer PM, Harris AL. Hypoxia-induced genetic instability-a calculated mechanism underlying tumor progression. J Mol Med (Berl) 85, 139–148, 2007.10.1007/s00109-006-0133-617180667
- Huang D, Li C, Zhang H. Hypoxia and cancer cell metabolism. Acta Biochim Biophys Sin (Shanghai) 46, 214–219, 2014.10.1093/abbs/gmt14824389642
- Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89, 479–491, 2004.10.1210/jc.2003-03109114764749
- Jaroszewski DE, Tessier DJ, Schlinkert RT, Grant CS, Thompson GB, van Heerden JA, Farley DR, Smith SL, Hinder RA. Laparoscopic adrenalectomy for pheochromocytoma. Mayo Clin Proc 78, 1501–1504, 2003.10.4065/78.12.150114661679
- Jimenez C, Waguespack SG. Functional imaging for pheochromocytoma-paraganglioma: a step closer to understanding its place in clinical practice. Endocrine 50, 6–8, 2015.10.1007/s12020-015-0672-026113425
- Jochmanova I, Yang C, Zhuang Z, Pacak K. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst 105, 1270–1283, 2013.10.1093/jnci/djt201388827923940289
- Jochmanova I, Pacak K. Pheochromocytoma: the first metabolic endocrine cancer. Clin Cancer Res 22, 5001–5011, 2016.10.1158/1078-0432.CCR-16-0606507408627742786
- Juarez D, Brown RW, Ostrowski M, Reardon MJ, Lechago J, Truong LD. Pheochromocytoma associated with neuroendocrine carcinoma. A new type of composite pheochromocytoma. Arch Pathol Lab Med 123, 1274–1279, 1999.10.5858/1999-123-1274-PAWNC10583935
- Karvonen H, Perttila R, Niininen W, Barker H, Ungureanu D. Targeting Wnt signaling pseudokinases in hematological cancers. Eur J Haematol 101, 457–465, 2018.10.1111/ejh.1313729989208
- Katoh M, Katoh M. Molecular genetics and targeted therapy of WNT-related human diseases. Int J Mol Med 40, 587–606, 2017.2873114810.3892/ijmm.2017.3071554794028731148
- Kawashima A, Sandler CM, Ernst RD, Takahashi N, Roubidoux MA, Goldman SM, Fishman EK, Dunnick NR. Imaging of nontraumatic hemorrhage of the adrenal gland. Radiographics 19, 949–963, 1999.10.1148/radiographics.19.4.g99jl1394910464802
- Keith B, Johnson RS, Simon MC. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12, 9–22, 2012.10.1038/nrc3183340191222169972
- Kenchegowda D, Natale B, Lemus MA, Natale DR, Fisher SA. Inactivation of maternal Hif-1α at mid-pregnancy causes placental defects and deficits in oxygen delivery to the fetal organs under hypoxic stress. Dev Biol 422, 171–185, 2017.10.1016/j.ydbio.2016.12.013530363527940158
- Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT. Laparoscopic curative resection of pheochromocytomas. Ann Surg 241, 919–928, 2005.10.1097/01.sla.0000164175.26785.06135717115912041
- Khatami F, Mohammadamoli M, Tavangar SM. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs). Endocr Regul 52, 41–54, 2018.2945391910.2478/enr-2018-000629453919
- Kiernan CM, Solorzano CC. Pheochromocytoma and paraganglioma: diagnosis, genetics, and treatment. Surg Oncol Clin N Am 25, 119–138, 2016.10.1016/j.soc.2015.08.006
- Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21, 405–414, 2014.10.1530/ERC-13-0494
- Kinney MAO, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 16, 359–369, 2005.10.1053/jcan.2002.124150
- Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171, 675–680, 1989.10.1148/radiology.171.3.2717737
- Kudva YC, Young Jr WF, Thompson GB, Grant CS, Van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. The Endocrinologist 9, 77–80, 1999.10.1097/00019616-199903000-00002
- Landsberg L. Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System. Chicago, Springer, 2018.10.1007/978-3-319-77048-2
- Lang B, Fu B, OuYang JZ, Wang BJ, Zhang GX, Xu K, Zhang J, Wang C, Shi TP, Zhou HX, Ma X, Zhang X. Retrospective comparison of retroperitoneoscopic versus open adrenalectomy for pheochromocytoma. J Urol 179, 57–60, 2008.10.1016/j.juro.2007.08.147
- Lee JK. Computed Body Tomography with MRI correlation. Lippincott Williams & Wilkins, 1998.
- Lenders JW, Pacak K, Eisenhofer G. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines. Ann N Y Acad Sci 970, 29–40, 2002a.10.1111/j.1749-6632.2002.tb04410.x
- Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287, 1427–1434, 2002b.10.1001/jama.287.11.1427
- Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 366, 665–675, 2005.10.1016/S0140-6736(05)67139-5
- Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99, 1915–1942, 2014.10.1210/jc.2014-149824893135
- Lenders JW, Eisenhofer G. Update on modern management of pheochromocytoma and paraganglioma. Endocrinol Metab (Seoul) 32, 152–161, 2017.2868550610.3803/EnM.2017.32.2.152550385928685506
- Lendvai N, Pawlosky R, Bullova P, Eisenhofer G, Patocs A, Veech RL, Pacak K. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings. Endocrinology 155, 27–32, 2014.10.1210/en.2013-1549539863624189137
- Lentschener C, Gaujoux S, Thillois J, Duboc D, Bertherat J, Ozier Y, Dousset B. Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma. Acta Anaesthesiol Scand 53, 522–527, 2009.10.1111/j.1399-6576.2008.01894.x19239408
- Lentschener C, Gaujoux S, Tesniere A, Dousset B. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? European Eur J Endocrinol 165, 365–373, 2011.10.1530/EJE-11-016221646289
- Leung K, Stamm M, Raja A, Low G. Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging. AJR Am J Roentgeno 200, 370–378, 2013.10.2214/AJR.12.912623345359
- Li J, Yang CH. Improvement of preoperative management in patients with adrenal pheochromocytoma. Int J Clin Exp Med 7, 5541–5546, 2014.
- Liao D, Johnson RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26, 281–290, 2007.10.1007/s10555-007-9066-y17603752
- Lloyd RV, Osamura RY, International Agency for Research on Can. WHO Classification of Tumours of Endocrine Organs. Lyon, WHO, 2017.
- Ludwig AD, Feig DI, Brandt ML, Hicks MJ, Fitch ME, Cass DL. Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg 194, 792–797, 2007.10.1016/j.amjsurg.2007.08.02818005773
- Lukashev D, Ohta A, Sitkovsky M. Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev 26, 273–279, 2007.10.1007/s10555-007-9054-217404693
- Luo W, Hu H, Chang R, Zhong J, Knabel M, O’Meally R, Cole RN, Pandey A, Semenza GL. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732–744, 2011.10.1016/j.cell.2011.03.054313056421620138
- Maitra A. The Endocrine System. Robbins and Cotran Pathologic Basis of Disease, Professional Edition (Eds. Kumar V, Abbas A, Fausto N, Aster J.). Phladelphia, PA, Saunders, Elsevier, 2010.10.1016/B978-1-4377-0792-2.50029-8
- Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40, 294–309, 2010.10.1016/j.molcel.2010.09.022314350820965423
- Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM, Mercurio AM. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17, 319–332, 2010.10.1016/j.ccr.2010.02.030288182220385358
- Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, Cao Y, Berkenstam A, Poellinger L. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550–554, 2001.10.1038/3510708511734856
- Malec K, Miskiewicz P, Witkowska A, Krajewska E, Toutounchi S, Galaka Z, Piotrowski M, Kacka A, Bednarczuk T, Ambroziak U. Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma. Kardiol Pol 75, 1192–1198, 2017.2871506610.5603/KP.a2017.014728715066
- Mallat J, Pironkov A, Destandau MS, Tavernier B. Systolic pressure variation (Deltadown) can guide fluid therapy during pheochromocytoma surgery. Can J Anaesth 50, 998–1003, 2003.10.1007/BF0301836214656776
- Manger WM. The protean manifestations of pheochromocytoma. Horm Metab Res 41, 658–663, 2009.1924289910.1055/s-0028-112813919242899
- Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85, 637–644, 2000.10.1210/jcem.85.2.637210690869
- Maurea S, Cuocolo A, Reynolds JC, Neumann RD, Salvatore M. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med 40, 365–371, 1996.9050342
- Mayo CH. Paroxysmal hypertension with tumor of retroperitoneal nerve: report of a case. JAMA 89, 1047–1050, 1927.10.1001/jama.1927.02690130035013
- Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, Vescovo G, Zuin M, Chondrogiannis S, Ravenni R, Opocher G, Colletti PM, Rubello D. Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45, 469–478, 2014.10.1007/s12020-013-0007-y2381783923817839
- McHenry CR. Pheochromocytoma: A clinical enigma. AACE Clinical Case Reports 3, e180–e181, 2017.10.4158/EP161587.CO
- McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med 30, 648–652, 2000.10.1111/j.1445-5994.2000.tb04358.x
- Megias MC, Puyol DR, Rodriguez LF, Martinez GLS, Miguel PM. Feocromocitoma-paraganglioma: del diagnostico bioquímico al genetico (Pheochromocytoma-paraganglioma: Biochemical and genetic diagnosis). Nefrologia 36, 481–488, 2016.10.1016/j.nefro.2016.03.010
- Melicow MM. One hundred cases of pheochromocytoma (107 tumors) at the Columbia and Presbyterian Medical Center, 1926–1976: a clinicopathological analysis. Cancer 40, 1987–2004, 1977.10.1002/1097-0142(197711)40:5<1987::AID-CNCR2820400502>3.0.CO;2-R
- Mercado-Asis LB, Wolf KI, Jochmanova I, Taieb D. Pheochromocytoma: A genetic and diagnostic update. Endocr Pract 24, 78–90, 2018.10.4158/EP-2017-0057
- Minno AM, Bennett WA, Kvale WF. Pheochromocytoma: a study of 15 cases diagnosed at autopsy. N Engl J Med 251, 959–965, 1954.10.1056/NEJM195412092512401
- Mirallie E, Jafari M, Pattou F, Ernst O, Huglo D, Carnaille B, Proye C. [Outcome of non-operated adrenal masses in 126 patients observed from 1986 to 1999]. Ann Chir 126, 212–220, 2001.10.1016/S0003-3944(01)00496-5
- Mirica A, Badarau IA, Stefanescu AM, Mirica R, Paun S, Stefan DAC, Paun DL. The role of chromogranin a in adrenal tumors. Revista de Chimie 69, 678–681, 2018.10.37358/RC.18.3.6174
- Mishra AK, Agarwal G, Kapoor A, Agarwal A, Bhatia E, Mishra SK. Catecholamine cardiomyopathy in bilateral malignant pheochromocytoma: successful reversal after surgery. Int J Cardiol 76, 89–90, 2000.10.1016/S0167-5273(00)00363-6
- Miyake H, Maeda H, Tashiro M, Suzuki K, Nagatomo H, Aikawa H, Ashizawa A, Iechika S, Moriuchi A. CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. AJR Am J Roentgenol 152, 1005–1007, 1989.10.2214/ajr.152.5.1005
- Moon KL Jr, Hricak H, Crooks LE, Gooding CA, Moss AA, Engelstad BL, Kaufman L. Nuclear magnetic resonance imaging of the adrenal gland: a preliminary report. Radiology 147, 155–160, 1983.10.1148/radiology.147.1.68287216828721
- Morrison PJ, Nevin NC. Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). J Med Genet 33, 779–782, 1996.10.1136/jmg.33.9.779888058110507358880581
- Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol 4, a011254, 2012.10.1101/cshperspect.a011254353634223125017
- Nakajima Y, Masaoka N, Sodeyama M, Tsuduki Y, Sakai M. Pheochromocytoma-related cardiomyopathy during the antepartum period in a preterm pregnant woman. J Obstet Gynaecol Res 37, 908–911, 2011.10.1111/j.1447-0756.2010.01423.x21736670
- Naranjo J, Dodd S, Martin YN. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 31, 1427–1439, 2017.10.1053/j.jvca.2017.02.02328392094
- Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan. Endocr J 65, 359–371, 2018.10.1507/endocrj.EJ17-02762935382129353821
- Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346, 1459–1466, 2002.10.1056/NEJMoa02015212000816
- Newhouse JH. MRI of the adrenal gland. Urol Radiol 12, 1–6, 1990.233366710.1007/BF029239542333667
- Nomura K, Kimura H, Shimizu S, Kodama H, Okamoto T, Obara T, Takano K. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy. J Clin Endocrinol Metab 94, 2850–2856, 2009.1947063010.1210/jc.2008-269719470630
- Nonaka K, Makuuchi H, Naruse Y, Kobayashi T, Goto M. Surgical excision of malignant pheochromocytoma in the left atrium. Jpn J Thorac Cardiovasc Surg 48, 126–128, 2000.10.1007/BF0321810610769996
- Oak S, Javid M, Callender GG, Carling T, Gibson CE. Management of pheochromocytoma in the setting of acute stroke. AACE Clinical Case Reports 4, e245–e248, 2018.10.4158/ACCR-2017-0077
- Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38, 6–8, 2001a.10.1161/01.HYP.38.1.611463751
- Pacak K, Fojo T, Goldstein DS, Eisenhofer G, Walther MM, Linehan WM, Bachenheimer L, Abraham J, Wood BJ. Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. J Natl Cancer Inst 93, 648–649, 2001b.10.1093/jnci/93.8.648238687811309443
- Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92, 4069–4079, 2007.1798912610.1210/jc.2007-172017989126
- Pacak K, Eisenhofer G, Ahlman Hk, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS; International Symposium on Pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3, 92–102, 2007.10.1038/ncpendmet039617237836
- Pacak K, Wimalawansa SJ. Pheochromocytoma and paraganglioma. Endocr Pract 21, 406–412, 2015.10.4158/EP14481.RA25716634
- Pamporaki C, Hamplova B, Peitzsch M, Prejbisz A, Beuschlein F, Timmers HJLM, Fassnacht M, Klink B, Lodish M, Stratakis CA, Huebner A, Fliedner S, Robledo M, Sinnott RO, Januszewicz A, Pacak K, Eisenhofer G. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 102, 1122–1132, 2017.10.1210/jc.2016-382928324046546072228324046
- Papadakis M, Manios A, Schoretsanitis G, Trompoukis C. Landmarks in the history of adrenal surgery. Hormones (Athens) 15, 136–141, 2016.10.1007/BF03401414
- Pappachan JM, Raskauskiene D, Sriraman R, Edavalath M, Hanna FW. Diagnosis and management of pheochromocytoma: a practical guide to clinicians. Curr Hypertens Rep 16, 442, 2014.2479209310.1007/s11906-014-0442-z24792093
- Pick L. Das Ganglioma embryonale sympathicum (Sympathoma embryonale). Berl Klin Wschnschr 49, 16–22, 1912.
- Pillai S, Gopalan V, Smith RA, Lam AK. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol Hematol 100, 190–208, 2016.10.1016/j.critrevonc.2016.01.02226839173
- Plesoianu CE, Andriescu G, Salaru D, Georgescu CA. The relationship between biochemical variables and the quality of life in patients with chronic heart failure. Rev Chim (Bucharest), 68, 2452–2458, 2017.10.37358/RC.17.10.5904
- Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 29, 1133–1139, 1997.914967810.1161/01.HYP.29.5.11339149678
- Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 86, 1480–1486, 2001.10.1210/jc.86.4.1480
- Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O; Guideline Working Group. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174, G1–G10, 2016.10.1530/EJE-16-003327048283
- Pogorzelski R, Toutounchi S, Krajewska E, Fiszer P, Lykowski M, Zapala L, Szostek M, Jakuczun W, Pachucki J, Skorski M. The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study. Cent European J Uro 67, 361–365, 2014.10.5173/ceju.2014.04.art9431089625667755
- Pollard P, Briere J, Alam N, Barwell J, Barclay E, Wortham N, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IP. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14, 2231–2239, 2005.10.1093/hmg/ddi22715987702
- Poopalalingam R, Chin EY. Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate. Can J Anaesth 48, 876–880, 2001.10.1007/BF030173531160634411606344
- Pourian M, Mostafazadeh DB, Soltani A. Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. J Diabetes Metab Disord 15, 11, 2016.10.1186/s40200-016-0226-x479717626998444
- Press D, Akyuz M, Dural C, Aliyev S, Monteiro R, Mino J, Mitchell J, Hamrahian A, Siperstein A, Berber E. Predictors of recurrence in pheochromocytoma. Surgery 156, 1523–1528, 2014.10.1016/j.surg.2014.08.04425456947
- Prinz RA. A comparison of laparoscopic and open adrenalectomies. Arch Surg 130, 489–494, 1995.10.1001/archsurg.1995.014300500390067748086
- Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100, 1154–1162, 1986.
- Raimundo N, Baysal BE, Shadel GS. Revisiting the TCA cycle: signaling to tumor formation. Trends Mol Med 17, 641–649, 2011.10.1016/j.molmed.2011.06.00121764377320530221764377
- Ramachandran R, Rewari V. Current perioperative management of pheochromocytomas. Indian J Urol 33, 19–25, 2017.2819702510.4103/0970-1591.194781
- Rao N, Ramachandran R, Tandon N, Singh P, Kumar R. Laparoscopic adrenalectomy for pheochromocytoma-does size matter? A single surgeon comparative study. Transl Androl Urol 5, 780–783, 2016.2778543610.21037/tau.2016.08.10507119127785436
- Renard J, Clerici T, Licker M, Triponez F. Pheochromocytoma and abdominal paraganglioma. J Visc Surg 148, e409–e416, 2011.10.1016/j.jviscsurg.2011.07.00321862435
- Reyes HA, Paquin JJ, Harris DM. Pheochromocytoma, “the Great Masquerader,” Presenting as Severe Acute Decompensated Heart Failure in a Young Patient. Case Rep Cardiol 2018, 8767801, 2018.10.1155/2018/8767801594918829854474
- Robbins SL, Kumar V. Basic Pathology, 4th Edition. Philadelphia, Saunders, 1987.10.1097/00006324-198708000-00014
- Rossitti HM, Soderkvist P, Gimm O. Extent of surgery for phaeochromocytomas in the genomic era. Br J Surg 105, e84–e98, 2018.10.1002/bjs.1074429341163
- Saffarini O. Open versus laparoscopic adrenalectomy for Pheochromocytoma. Diploma In Minimal Access Surgery, Laparoscopy Hospital, New Delhi, India, 2007.
- Sanford EL, Hickey T, Lu J. Acute Takotsubo cardiomyopathy during elective hernia repair in a patient with previously resected pheochromocytoma. J Cardiothorac Vasc Anesth 29, 1596–1598, 2015.10.1053/j.jvca.2014.12.00125813227
- Scheffler IE. Mitochondria. New Jersey, Wiley and Sons, Inc., 2008.
- Schenker JG, Granat M. Phaeochromocytoma and pregnancy-an updated appraisal. Aust N Z J Obstet Gynaecol 22, 1–10, 1982.10.1111/j.1479-828X.1982.tb01388.x
- Scholten A, Cisco RM, Vriens MR, Cohen JK, Mitmaker EJ, Liu C, Tyrrell JB, Shen WT, Duh QY. Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab 98, 581–591, 2013.10.1210/jc.2012-302023284003
- Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12, 667–680, 2005.10.1677/erc.1.010291617219916172199
- Schultz CL, Haaga JR, Fletcher BD, Alfidi RJ, Schultz MA. Magnetic resonance imaging of the adrenal glands: a comparison with computed tomography. AJR Am J Roentgenol 143, 1235–1240, 1984.10.2214/ajr.143.6.12356333793
- Schulz C, Eisenhofer G, Lehnert H. Principles of catecholamine biosynthesis, metabolism and release. Front Horm Res. 31, 1–25, 2004.10.1159/00007465614674302
- Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77–85, 2005.10.1016/j.ccr.2004.11.0221565275115652751
- Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721–732, 2003.10.1038/nrc118713130303
- Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625–634, 2010.10.1038/onc.2009.441296916819946328
- Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399–408, 2012.10.1016/j.cell.2012.01.021343754322304911
- Shawar L, Svec F. Pheochromocytoma with elevated metanephrines as the only biochemical finding. J La State Med Soc 148, 535–538, 1996.
- Shulkin BL, Ilias I, Sisson JC, Pacak K. Current trends in functional imaging of pheochromocytomas and paragangliomas. Ann N Y Acad Sci 1073, 374–382, 2006.10.1196/annals.1353.04117102106
- Siddiqi HK, Yang HY, Laird AM, Fox AC, Doherty GM, Miller BS, Gauger PG. Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery 152, 1027–1036, 2012.10.1016/j.surg.2012.08.02323158177
- Sinclair D, Shenkin A, Lorimer A. Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma. Ann Clin Biochem 28, 417–419, 1991.10.1177/0004563291028004201892355
- Soltani A, Pourian M, Davani BM. Correction to: Does this patient have Pheochromocytoma? a systematic review of clinical signs and symptoms. J Diabetes Metab Disord 16, 42, 2017.10.1186/s40200-017-0324-4564405929046871
- Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution‘s experience. Medicine (Baltimore) 70, 46–66, 1991.10.1097/00005792-199101000-000041988766
- Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr. Metyrosine and pheochromocytoma. Arch Intern Med 157, 901–906, 1997.10.1001/archinte.157.8.901
- Sternberg SS, Antonioli DA, Carter D, Mills SE, Oberman HA. Diagnostic Surgical Pathology, 3rd ed., Vol. 2. Philadelphia, PA, USA, Lippincott, Williams & Wilkins, 1999.
- Stewart MF, Reed P, Weinkove C, Moriarty KJ, Ralston AJ. Biochemical diagnosis of phaeochromocytoma: two instructive case reports. J Clin Pathol 46, 280–282, 1993.10.1136/jcp.46.3.28084634265011898463426
- Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56, 354–360, 1981.
- Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26, 299–310, 2007.10.1007/s10555-007-9064-017415526
- Tanaka M, Tokuda N, Koga H, Kimoto Y, Naito S. Laparoscopic adrenalectomy for pheochromocytoma: comparison with open adrenalectomy and comparison of laparoscopic surgery for pheochromocytoma versus other adrenal tumors. J Endourol 14, 427–431, 2000.10.1089/end.2000.14.4271095856510958565
- Thanapaalasingham K, Pollmann AS, Schelew B. Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report. Can J Anaesth 62, 1303–1307, 2015.2636280010.1007/s12630-015-0480-226362800
- Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26, 551–566, 2002.10.1097/00000478-200205000-0000211979086
- Thomson BN, Moulton CA, Davies M, Banting SW. Laparoscopic adrenalectomy for phaeochromocytoma: with caution. ANZ J Surg 74, 429–433, 2004.10.1111/j.1445-1433.2004.03024.x1519147315191473
- Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J, Tops CM, Firth H, Dwight T Ercolino T1, Mannelli M, Opocher G, Clifton-Bligh R, Gimm O, Maher ER, Robledo M, Gimenez-Roqueplo AP, Dahia PL, NGS in PPGL (NGSnPPGL) Study Group. Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 13, 233–247, 2017.10.1038/nrendo.2016.18527857127
- Toledo R, Jimenez C. Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors. F1000Res 7, pii: F1000 Faculty Rev-1148, 2018.10.12688/f1000research.13995.1
- Toniato A, Piotto A, Pagetta C, Bernante P, Pelizzo M. Technique and results of laparoscopic adrenalectomy. Langenbecks Arch Surg 386, 200–203, 2001.10.1007/s00423010023111382322
- Toniato A, Boschin IM, Opocher G, Guolo A, Pelizzo M, Mantero F. Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? Surgery 141, 723–727, 2007.10.1016/j.surg.2006.10.01217560248
- Townsend CM, Beauchanp RD, Evers BM, Mattox KL. Sabiston Textbook of Surgery, 19th Ed., Elsevier Publishers, 2012.
- Tschuor C, Sadri H, Clavien PA. Pheochromocytoma crisis. Clin Case Rep 2, 14, 2014.10.1002/ccr3.6418476625356229
- Turchini J, Gill AJ, Tischler AS. Pathology of Pheochromocytoma and Paraganglioma. In: Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System (ed. Landsberg L). Humana Press, Springer, 2018.10.1007/978-3-319-77048-2_2
- Udelsman R. Adrenal. In: Surgery, Basic Science and Clinical Evidence (eds. Norton JA, Bollinger RR). Bollinger, Springer, 2001.
- Unger N, Hinrichs J, Deutschbein T, Schmidt H, Walz M, Mann K, Petersenn S. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass. Exp Clin Endocrinol Diabetes 120, 494–500, 2012.10.1055/s-0032-130900722696168
- van Berkel A, Lenders JW, Timmers HJ. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma. Eur J Endocrinol 170, R109–R119, 2014.10.1530/EJE-13-088224347425
- van der Weerd K, van Noord C, Loeve M, Knapen M, Visser W, de Herder W, Franssen G, van der Marel C, Feelders R. Endocrinology in pregnancy: Pheochromocytoma in pregnancy: case series and review of literature. Eur J Endocrinol 177, R49–R58, 2017.10.1530/EJE-16-092028381449
- von Schlegel GG. Neurofibromatose recklinghausen und phaochromocytom. Schweiz Med Wochenschr 90, 31–39, 1960.
- Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95, 2023–2037, 2010.10.1210/jc.2009-283020215394
- Wang Y, Liu Y, Malek SN, Zheng P, Liu Y. Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8, 399–411, 2011.10.1016/j.stem.2011.02.006308459521474104
- Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 8, 519–530, 1927.10.1085/jgp.8.6.519214082019872213
- Weiner MM, Asher DI, Augoustides JG, Evans AS, Patel PA, Gutsche JT, Mookadam F, Ramakrishna H. Takotsubo cardiomyopathy: A clinical update for the cardiovascular anesthesiologist. J Cardiothorac Vasc Anesth 31, 334–344, 2017.2754683110.1053/j.jvca.2016.06.00427546831
- Weingarten TN, Cata JP, O‘Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E, Sprung J. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76, 508.e6–508.e11, 2010.10.1016/j.urology.2010.03.03220546874
- Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM, Cancer Genome Atlas Research Network. The cancer genome atlas pan-cancer analysis project. Nat Genet 45, 1113–1120, 2013.10.1038/ng.2764391996924071849
- Welander J, Larsson C, Backdahl M, Hareni N, Sivler T, Brauckhoff M, Soderkvist P, Gimm O. Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. Hum Mol Genet 21, 5406–5416, 2012.10.1093/hmg/dds40223010473
- Welbourn RB. Early surgical history of phaeochromocytoma. Br J Surg 74, 594–596, 1987.10.1002/bjs.18007407173304519
- Wiese KE, Nusse R, van Amerongen R. Wnt signalling: conquering complexity. Development 145, dev165902, 2018.10.1242/dev.16590229945986
- Wiesener MS, Jurgensen JS, Rosenberger C, Scholdge CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt KU. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 17, 271–273, 2003.10.1096/fj.02-0445fje1249053912490539
- Wing LA, Conaglen JV, Meyer-Rochow GY, Elston MS. Paraganglioma in pregnancy: a case series and review of the literature. J Clin Endocrinol Metab 100, 3202–3209, 2015.10.1210/jc.2015-212226083822
- Wyszynska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 81, 244–246, 1992.10.1111/j.1651-2227.1992.tb12213.x1511199
- Yu R, Wei M. False positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes 118, 577–585, 2010.10.1055/s-0029-123769919998239
- Yumi H, Guidelines Committee of the Society of American Gastrointestinal and Endoscopic Surgeons. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surg Endosc 22, 849–861, 2008.10.1007/s00464-008-9758-618288533
- Zhikrivetskaya SO, Snezhkina AV, Zaretsky AR, Alekseev BY, Pokrovsky AV, Golovyuk AL, Melnikova NV, Stepanov OA, Kalinin DV, Moskalev AA, Krasnov GS, Dmitriev AA, Kudryavtseva AV. Molecular markers of paragangliomas/pheochromocytomas. Oncotarget 8, 25756–25782, 2017.2818700110.18632/oncotarget.15201
- Zhu H, Bunn HF. Oxygen sensing and signaling: impact on the regulation of physiologically important genes. Respir Physiol 115, 239–247, 1999.10.1016/S0034-5687(99)00024-9